<?xml version='1.0' encoding='utf-8'?>
<document id="28975396"><sentence text="Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients."><entity charOffset="0-10" id="DDI-PubMed.28975396.s1.e0" text="Colchicine" /><entity charOffset="71-85" id="DDI-PubMed.28975396.s1.e1" text="clarithromycin" /><pair ddi="false" e1="DDI-PubMed.28975396.s1.e0" e2="DDI-PubMed.28975396.s1.e0" /><pair ddi="false" e1="DDI-PubMed.28975396.s1.e0" e2="DDI-PubMed.28975396.s1.e1" /></sentence><sentence text="Familial Mediterranean fever is a hereditary disease, characterized by recurrent episodes of inflammation" /><sentence text=" Colchicine, the mainstay of therapy, is administered continuously to all diagnosed FMF patients"><entity charOffset="1-11" id="DDI-PubMed.28975396.s3.e0" text="Colchicine" /></sentence><sentence text=" Drug-drug interaction between colchicine and clarithromycin, resulting in colchicine intoxication, has been noted, mainly in association with gout and pneumonia"><entity charOffset="31-41" id="DDI-PubMed.28975396.s4.e0" text="colchicine" /><entity charOffset="46-60" id="DDI-PubMed.28975396.s4.e1" text="clarithromycin" /><entity charOffset="75-85" id="DDI-PubMed.28975396.s4.e2" text="colchicine" /><pair ddi="false" e1="DDI-PubMed.28975396.s4.e0" e2="DDI-PubMed.28975396.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28975396.s4.e0" e2="DDI-PubMed.28975396.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28975396.s4.e0" e2="DDI-PubMed.28975396.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28975396.s4.e1" e2="DDI-PubMed.28975396.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28975396.s4.e1" e2="DDI-PubMed.28975396.s4.e2" /></sentence><sentence text=" In FMF, this adverse event has been scarcely described" /><sentence text=" We present and characterize six patients with clarithromycin-related colchicine intoxication, aiming mainly at characterizing the FMF-specific features of this event"><entity charOffset="47-61" id="DDI-PubMed.28975396.s6.e0" text="clarithromycin" /><entity charOffset="70-80" id="DDI-PubMed.28975396.s6.e1" text="colchicine" /><pair ddi="false" e1="DDI-PubMed.28975396.s6.e0" e2="DDI-PubMed.28975396.s6.e0" /><pair ddi="false" e1="DDI-PubMed.28975396.s6.e0" e2="DDI-PubMed.28975396.s6.e1" /></sentence><sentence text=" This study is a retrospective analysis, based on clinical and hospital records of all FMF patients admitted to one hospital during 2002-2015, for colchicine intoxication, precipitated by consumption of clarithromycin"><entity charOffset="147-157" id="DDI-PubMed.28975396.s7.e0" text="colchicine" /><entity charOffset="203-217" id="DDI-PubMed.28975396.s7.e1" text="clarithromycin" /><pair ddi="false" e1="DDI-PubMed.28975396.s7.e0" e2="DDI-PubMed.28975396.s7.e0" /><pair ddi="false" e1="DDI-PubMed.28975396.s7.e0" e2="DDI-PubMed.28975396.s7.e1" /></sentence><sentence text=" All six patients were women who received colchicine for FMF, and clarithromycin for Helicobacter pylori (HBP) gastric infection"><entity charOffset="42-52" id="DDI-PubMed.28975396.s8.e0" text="colchicine" /><entity charOffset="57-60" id="DDI-PubMed.28975396.s8.e1" text="FMF" /><entity charOffset="66-80" id="DDI-PubMed.28975396.s8.e2" text="clarithromycin" /><pair ddi="false" e1="DDI-PubMed.28975396.s8.e0" e2="DDI-PubMed.28975396.s8.e0" /><pair ddi="false" e1="DDI-PubMed.28975396.s8.e0" e2="DDI-PubMed.28975396.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28975396.s8.e0" e2="DDI-PubMed.28975396.s8.e2" /><pair ddi="false" e1="DDI-PubMed.28975396.s8.e1" e2="DDI-PubMed.28975396.s8.e1" /><pair ddi="false" e1="DDI-PubMed.28975396.s8.e1" e2="DDI-PubMed.28975396.s8.e2" /></sentence><sentence text=" Their daily dosages of colchicine ranged from 1"><entity charOffset="24-34" id="DDI-PubMed.28975396.s9.e0" text="colchicine" /></sentence><sentence text="5 to 2" /><sentence text="5Â mg" /><sentence text=" Two had mild FMF, two moderate and two severe diseases"><entity charOffset="14-23" id="DDI-PubMed.28975396.s12.e0" text="FMF" /></sentence><sentence text=" Colchicine intoxication occurred despite intact kidney function and was characterized by abdominal pain, diarrhea, weakness, rhabdomyolysis, hepatitis, kidney impairment and bone marrow injury"><entity charOffset="1-11" id="DDI-PubMed.28975396.s13.e0" text="Colchicine" /></sentence><sentence text=" It is concluded that clarithromycin-induced colchicine intoxication is a hazard in FMF"><entity charOffset="22-36" id="DDI-PubMed.28975396.s14.e0" text="clarithromycin" /><entity charOffset="45-55" id="DDI-PubMed.28975396.s14.e1" text="colchicine" /><entity charOffset="84-93" id="DDI-PubMed.28975396.s14.e2" text="FMF" /><pair ddi="false" e1="DDI-PubMed.28975396.s14.e0" e2="DDI-PubMed.28975396.s14.e0" /><pair ddi="false" e1="DDI-PubMed.28975396.s14.e0" e2="DDI-PubMed.28975396.s14.e1" /><pair ddi="false" e1="DDI-PubMed.28975396.s14.e0" e2="DDI-PubMed.28975396.s14.e2" /><pair ddi="false" e1="DDI-PubMed.28975396.s14.e1" e2="DDI-PubMed.28975396.s14.e1" /><pair ddi="false" e1="DDI-PubMed.28975396.s14.e1" e2="DDI-PubMed.28975396.s14.e2" /></sentence><sentence text=" It occurs despite normal kidney function and standard colchicine dose and is associated with female sex and moderate to severe FMF"><entity charOffset="55-65" id="DDI-PubMed.28975396.s15.e0" text="colchicine" /><entity charOffset="128-137" id="DDI-PubMed.28975396.s15.e1" text="FMF" /><pair ddi="false" e1="DDI-PubMed.28975396.s15.e0" e2="DDI-PubMed.28975396.s15.e0" /><pair ddi="false" e1="DDI-PubMed.28975396.s15.e0" e2="DDI-PubMed.28975396.s15.e1" /></sentence><sentence text="" /></document>